April 10, 2024
Otsuka Pharmaceutical and Danish ally Lundbeck said on April 9 that they have filed their antipsychotic Rexulti (brexpiprazole) in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD) in the US. The submission, dated April 8,...read more